JP2025138639A5 - - Google Patents

Info

Publication number
JP2025138639A5
JP2025138639A5 JP2025088639A JP2025088639A JP2025138639A5 JP 2025138639 A5 JP2025138639 A5 JP 2025138639A5 JP 2025088639 A JP2025088639 A JP 2025088639A JP 2025088639 A JP2025088639 A JP 2025088639A JP 2025138639 A5 JP2025138639 A5 JP 2025138639A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025088639A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025138639A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/050890 external-priority patent/WO2020056191A1/en
Application filed filed Critical
Publication of JP2025138639A publication Critical patent/JP2025138639A/ja
Publication of JP2025138639A5 publication Critical patent/JP2025138639A5/ja
Pending legal-status Critical Current

Links

JP2025088639A 2018-09-13 2025-05-28 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用 Pending JP2025138639A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862731076P 2018-09-13 2018-09-13
US62/731,076 2018-09-13
PCT/US2019/050890 WO2020056191A1 (en) 2018-09-13 2019-09-12 Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
JP2021514400A JP7777448B2 (ja) 2018-09-13 2019-09-12 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021514400A Division JP7777448B2 (ja) 2018-09-13 2019-09-12 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Publications (2)

Publication Number Publication Date
JP2025138639A JP2025138639A (ja) 2025-09-25
JP2025138639A5 true JP2025138639A5 (https=) 2026-02-13

Family

ID=68073184

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021514400A Active JP7777448B2 (ja) 2018-09-13 2019-09-12 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用
JP2025088639A Pending JP2025138639A (ja) 2018-09-13 2025-05-28 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021514400A Active JP7777448B2 (ja) 2018-09-13 2019-09-12 プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI-1)阻害剤(inhibitor)の使用

Country Status (12)

Country Link
US (1) US20220079911A1 (https=)
EP (1) EP3849540A1 (https=)
JP (2) JP7777448B2 (https=)
KR (2) KR20250161056A (https=)
CN (2) CN120899921A (https=)
AU (1) AU2019339488B2 (https=)
BR (1) BR112021004550A2 (https=)
CA (1) CA3112549A1 (https=)
IL (1) IL281451A (https=)
MX (2) MX2021002994A (https=)
SG (1) SG11202102479TA (https=)
WO (1) WO2020056191A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019005833A (es) 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
AU2024344613A1 (en) * 2023-09-18 2026-04-23 Eirion Therapeutics, Inc. Topical compositions and uses of pai-1 inhibitors
CN117919248B (zh) * 2024-03-22 2024-06-04 四川兴泰普乐医疗科技有限公司 一种可注射生发组合物及其制备方法和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US296006A (en) 1884-04-01 John hoefleb
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
CA1283827C (en) 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US6461596B1 (en) * 1997-02-18 2002-10-08 Andrea Taylor Composition and method for promoting hair growth
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US5965154A (en) 1998-03-17 1999-10-12 Plc Holding, L.L.C. Adhesive matrix type transdermal patch and method of manufacturing same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6908453B2 (en) 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
WO2003071267A1 (en) * 2002-02-19 2003-08-28 Vanderbilt University Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
US20060058369A1 (en) * 2002-02-19 2006-03-16 Vanderbilt University Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors
JP2006507297A (ja) * 2002-05-13 2006-03-02 チルドレンズ・ホスピタル・ロサンジェルス ケロイドおよび他の皮膚または内部創傷または病変における異常瘢痕形成の処置および予防
KR102110379B1 (ko) 2005-12-01 2020-05-14 유니버시티 오브 메사츄세츠 로웰 보툴리눔 나노에멀젼
US8658391B2 (en) 2006-04-27 2014-02-25 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
CA2691214A1 (en) * 2006-06-09 2007-12-21 Kemia, Inc. Therapy using cytokine inhibitors
SG177184A1 (en) 2006-12-01 2012-01-30 Anterios Inc Amphiphilic entity nanoparticles
EP2272822A4 (en) * 2008-03-31 2012-01-18 Renascience Co Ltd PLASMINOG ACTIVATOR-1 HEMMER
WO2009143865A1 (en) * 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
KR101848095B1 (ko) 2008-06-26 2018-04-11 안테리오스, 인코퍼레이티드 경피 운반
TW201117810A (en) * 2009-10-01 2011-06-01 Baylor Res Inst Treatment of male-pattern baldness by local induction of the metabolic defect of fabry disease
US20120328701A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
BR112013018918A2 (pt) 2011-01-24 2016-10-04 Anterios Inc composições de nanopartículas
US9144671B2 (en) 2011-12-21 2015-09-29 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
CN103479627A (zh) * 2013-05-16 2014-01-01 武汉光谷百桥国际生物科技有限公司 一种血管紧张素ii的i型受体拮抗剂在促进毛发生长方面的应用
AU2015337807B2 (en) * 2014-10-29 2017-05-04 Samson Clinical Pty Ltd Detection and treatment of excessive hair shedding
US20160144001A1 (en) * 2014-11-21 2016-05-26 Northwestern University Methods and compositions for modulating fgf23 levels

Similar Documents

Publication Publication Date Title
JP2023085489A5 (https=)
JP2023105131A5 (https=)
JP2024036694A5 (https=)
JP2024032941A5 (https=)
JP2021151238A5 (https=)
JP2023052878A5 (https=)
JP2024059739A5 (https=)
JP2023526975A5 (https=)
JP2021048879A5 (https=)
JP2025069142A5 (https=)
JP2022122972A5 (https=)
JP2024150466A5 (https=)
JP2022185040A5 (https=)
JP2021100406A5 (https=)
JP2023182571A5 (https=)
JP2024026077A5 (https=)
JP2023133317A5 (https=)
JP2024112817A5 (https=)
JP2025084837A5 (https=)
JP2023116477A5 (https=)
JP2020079331A5 (https=)
JP2022064180A5 (https=)
JP2022518056A5 (https=)
JP2024063214A5 (https=)
JP2025138639A5 (https=)